4//SEC Filing
Sikri Vishal 4
Accession 0001077183-24-000026
CIK 0001077183other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:27 PM ET
Size
17.7 KB
Accession
0001077183-24-000026
Insider Transaction Report
Form 4
Sikri Vishal
President and CCO, Inivata
Transactions
- Award
Stock Option (Right to Buy)
2024-02-23+42,344→ 42,344 totalExercise: $16.45Exp: 2034-02-23→ Common Stock (42,344 underlying) - Award
Restricted Stock Unit
2024-02-23+25,329→ 25,329 totalExercise: $0.00→ Common Stock (25,329 underlying) - Award
Performance Stock Unit
2024-02-23+25,330→ 25,330 totalExercise: $0.00From: 2027-02-23→ Common Stock (25,330 underlying)
Holdings
- 128,921
Common Stock
- 319,112
Stock Option (Right to Buy)
Exercise: $8.42Exp: 2029-06-01→ Common Stock (319,112 underlying) - 39,683
Stock Option (Right to Buy)
Exercise: $19.65Exp: 2030-05-11→ Common Stock (39,683 underlying) - 21,204
Restricted Stock Unit
Exercise: $0.00→ Common Stock (21,204 underlying) - 21,204
Performance Stock Unit
Exercise: $0.00From: 2026-05-11→ Common Stock (21,204 underlying)
Footnotes (10)
- [F1]This balance includes 1,205 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
- [F10]On February 23, 2024, Mr. Sikri was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
- [F2]On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.
- [F3]On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On May 11, 2023, Mr. Sikri was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F5]On May 11, 2023, Mr. Sikri was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F6]Once vested, the shares of common stock are not subject to expiration.
- [F7]On May 11, 2023, Mr. Sikri was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
- [F8]On February 23, 2024, Mr. Sikri was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F9]On February 23, 2024, Mr. Sikri was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001931406
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:27 PM ET
- Size
- 17.7 KB